Dear business partners and customers of NOBLEX!
In 2016 VF Capital took over the shares of the optics division Eisfeld from Analytik Jena AG. At the Eisfeld site, complex and high-quality optoelectronic modules and complete optical devices are developed and manufactured. The new brand NOBLEX was established and stocks of the old Docter Optik brand, which could no longer be used for trademark reasons, were gradually sold out. In the following years, strategic investments were made in new products and machines and the product range was supplemented by modern high-performance products.
NOBLEX GmbH has a further business division in which manufacturing services are carried out for external companies. In addition to the assembly of complex, high-quality devices and components, turned and milled parts are produced and the surfaces are finished by anodizing or painting.
In the course of the Corona COVD-19 pandemic, the company suffered in both business units, particularly in exports, in some cases massive losses in sales, which continue to have a negative impact on the company's financial situation today. Due to the substantial investments made in previous years, the shareholders were no longer able to compensate for these losses in the short term. The management therefore filed an application for the initiation of a protective shielding procedure in June 2020. The opening of the proceedings took place after 3 months and the previous administrator Dr. Markus Schädler from Bendel Insolvenzverwaltung AG was appointed insolvency administrator by the Meiningen Local Court on September 1, 2020.
Good chances for restructuring
Business operations will continue in full under the conditions of insolvency law, so that all customer orders can be processed on time. If you have any questions regarding the availability of products or repairs, please contact Susann Adam at +49 3686 371115 This email address is being protected from spambots. You need JavaScript enabled to view it.
In the course of the proceedings, talks are currently being held with investors in order to ensure the continuation of the company in the long term.
For further questions or information on the proceedings, please contact Dr. Markus Schädler + 49 9721 3860950, This email address is being protected from spambots. You need JavaScript enabled to view it..
The NOBLEX Team